Skip to main content

TRIPS Agreement: Coronavirus

Question for Department for International Trade

UIN 77440, tabled on 18 November 2021

To ask the Secretary of State for International Trade, what recent assessment she has made of the (a) national and (b) international potential merits of introducing a TRIPS waiver in respect of covid-19 related (i) vaccines and (ii) vaccine technology.

Answered on

23 November 2021

Whilst HM Government has not seen evidence that Intellectual Property (IP) is a barrier to the production or supply of COVID-19 goods, including vaccines, we will continue to engage constructively in debates at the World Trade Organisation (WTO) Trade-Related Aspects of Intellectual Property Rights Council and other international institutions to promote affordable and equitable global access to COVID-19 vaccines for all.

The United Kingdom affirmed this commitment in the G7 Trade Ministers’ communique of 22nd October, which notes our determination to achieve an impactful outcome on trade and health, including how the international IP framework can best support the WTO’s pandemic response.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.